Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Kaposi × lenvatinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 35 Parkinson Disease 4, Autosomal Dominant Lewy Body 26 Carcinoma, Renal Cell 21 Melanoma 10 Endometrial Neoplasms 10 Neoplasms 9 Cholangiocarcinoma 8 Biliary Tract Neoplasms 7 Uterine Cervical Neoplasms 6 Liver Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Triple Negative Breast Neoplasms 4 Thyroid Neoplasms 4 Stomach Neoplasms 4 Recurrence 4 Ovarian Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Esophageal Squamous Cell Carcinoma 3 Diabetes Mellitus, Insulin-Dependent, 12 3 Breast Neoplasms 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Uveal Melanoma 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Pancreatic Neoplasms 2 Kidney Neoplasms 2

Interventions

Nivolumab 4 pomalidomide 2 pembrolizumab 2 liposomal doxorubicin 2 Specimen Handling 2 Propranolol 2 Magnetic Resonance Spectroscopy 2 lenvatinib 1 ixazomib 1 cabozantinib 1 abemaciclib 1 Paclitaxel 1 Nelfinavir 1 NHS-IL12 immunocytokine 1 Ipilimumab 1 CTLA-4 Antigen 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05846724 2026-01-22

PULSAR

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Phase 2 Withdrawn

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡